The Complete Guide to Gut Signals That Control Hunger and Fullness
Multiple gut-derived peptide signals (CCK, GLP-1, PYY, ghrelin, oxyntomodulin) control meal-to-meal satiety while long-term fat signals (leptin, insulin) regulate body weight — an integrated two-tier system.
Quick Facts
What This Study Found
Satiety is controlled by a two-tier peripheral signaling system: short-term gut peptides (CCK, GLP-1, PYY, ghrelin, oxyntomodulin) for meal control and long-term adiposity signals (leptin, insulin) for body weight regulation, integrated by brainstem and hypothalamic circuits.
Key Numbers
How They Did This
Comprehensive review of all peripheral satiety and hunger signals, their receptors, neural pathways, and integration in central appetite circuits.
Why This Research Matters
This review describes the complete signaling architecture that modern obesity drugs target. GLP-1 agonists (semaglutide) work through one of the many pathways described here.
The Bigger Picture
Understanding the full appetite signaling network reveals why single-target drugs have limited weight loss. The most effective future treatments may combine signals from multiple tiers.
What This Study Doesn't Tell Us
Review from 2003. Some signals described were still being characterized. The relative importance of each signal for human obesity treatment was debated.
Questions This Raises
- ?Can multi-signal targeting achieve greater weight loss than GLP-1 alone?
- ?Which combination of gut peptide mimetics would be most effective?
- ?Does chronic obesity alter the sensitivity of these signaling pathways?
Trust & Context
- Key Stat:
- Two-tier system Meal-by-meal gut signals + long-term fat signals = the complete appetite control architecture that modern obesity drugs target
- Evidence Grade:
- Strong evidence from a comprehensive review synthesizing decades of appetite physiology research.
- Study Age:
- Published in 2003. This framework has been validated by the clinical success of GLP-1 agonists (semaglutide) and combined GLP-1/GIP drugs (tirzepatide).
- Original Title:
- Peripheral signals in the control of satiety and hunger.
- Published In:
- Current opinion in clinical nutrition and metabolic care, 6(6), 621-9 (2003)
- Authors:
- Drazen, Deborah L, Woods, Stephen C(5)
- Database ID:
- RPEP-00813
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
Why is appetite so complex?
Because survival depends on eating the right amount. The body uses multiple overlapping signals — from the gut, fat tissue, and brain — to ensure you eat enough but not too much. Each signal provides different information.
How do current obesity drugs fit in?
Semaglutide (Ozempic) mimics GLP-1, just one of the many gut peptide signals described here. Newer drugs like tirzepatide target two signals (GLP-1 + GIP). Future drugs may target even more for greater effectiveness.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00813APA
Drazen, Deborah L; Woods, Stephen C. (2003). Peripheral signals in the control of satiety and hunger.. Current opinion in clinical nutrition and metabolic care, 6(6), 621-9.
MLA
Drazen, Deborah L, et al. "Peripheral signals in the control of satiety and hunger.." Current opinion in clinical nutrition and metabolic care, 2003.
RethinkPeptides
RethinkPeptides Research Database. "Peripheral signals in the control of satiety and hunger." RPEP-00813. Retrieved from https://rethinkpeptides.com/research/drazen-2003-peripheral-signals-in-the
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.